Join the club for FREE to access the whole archive and other member benefits.

Why a drug for aging would challenge Washington


Key points from article :

What if just one medical treatment could stave off heart disease, cancer and Alzheimer’s?

First human studies of anti-aging drugs are getting underway.

Aging isn’t considered a disease by the FDA.

Idea is to get a potential drug approved first under more traditional protocols.

The longer they will draw from Social Security and other government benefit programs.

But healthier people will require less medical care in the final years of their lives.

Might backfire by encouraging people to skimp on healthy habits like eating right or exercising.

Mentioned in this article:

Tap on icon for description, click on resource name for more details.


Researcher on different aging related diseases.


Associate Professor at Biomedical Ethics Unit at McGill University.


Professor of Biochemistry, Molecular Biology and Biophysics at the University of Minnesota.


Founding director of the Institute for Aging Research.


Professor of Public Health at University of Illinois at Chicago.